Search by Drug Name or NDC
NDC 17433-9877-05 ENEMEEZ Plus 20; 283 mg/5mL; mg/5mL Details
ENEMEEZ Plus 20; 283 mg/5mL; mg/5mL
ENEMEEZ Plus is a RECTAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Enemeez LLC DBA Summit Pharmaceuticals. The primary component is BENZOCAINE; DOCUSATE SODIUM.
Product Information
| NDC | 17433-9877 |
|---|---|
| Product ID | 17433-9877_0555d5ed-ff59-3e3c-e063-6294a90a9949 |
| Associated GPIs | 46500010055120 |
| GCN Sequence Number | 068186 |
| GCN Sequence Number Description | docusate sodium/benzocaine ENEMA 283-20MG/5 RECTAL |
| HIC3 | Q3S |
| HIC3 Description | LAXATIVES, LOCAL/RECTAL |
| GCN | 30915 |
| HICL Sequence Number | 001321 |
| HICL Sequence Number Description | DOCUSATE SODIUM/BENZOCAINE |
| Brand/Generic | Brand |
| Proprietary Name | ENEMEEZ Plus |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | docusate sodium and benzocaine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | RECTAL |
| Active Ingredient Strength | 20; 283 |
| Active Ingredient Units | mg/5mL; mg/5mL |
| Substance Name | BENZOCAINE; DOCUSATE SODIUM |
| Labeler Name | Enemeez LLC DBA Summit Pharmaceuticals |
| Pharmaceutical Class | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 17433-9877-05 (17433987705)
| NDC Package Code | 17433-9877-5 |
|---|---|
| Billing NDC | 17433987705 |
| Package | 5 TUBE in 1 CONTAINER (17433-9877-5) / 5 mL in 1 TUBE (17433-9877-0) |
| Marketing Start Date | 2022-01-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |